AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm

Accessibility StatementSkip Navigation SOURCE The Schall Law Firm WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+NewsroomsÂ &Influencers 9k+DigitalÂ MediaOutlets 270k+JournalistsOpted In GET STARTED LOS ANGELES, Sept. 18, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofÂ Agios Pharmaceuticals, Inc. ("Agios" or "the Company") (NASDAQ: AGIO) for violations of the securities laws. The investig ...